These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 683753)

  • 21. Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma.
    Wu MC; Yunis AA
    Int J Biochem; 1979; 10(12):1001-6. PubMed ID: 116877
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative studies on two active enzyme forms of human urinary urokinase. II. pH-and heat-stabilities of plasminogen activator activity.
    Miwa N; Obata Y; Suzuki A
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):472-5. PubMed ID: 7023710
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen].
    Roncato M; Vitoux JF; Pernes JM; Aiach M; Fiessinger JN; Gaux JC; Housset E; Leclerc M
    Ann Biol Clin (Paris); 1985; 43(6):851-5. PubMed ID: 3832977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes.
    Vasse M; Mirshahi SS; Soria J; Mirshahi M; Borg JY; Monconduit M; Soria C
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):143-7. PubMed ID: 8457643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrin and fibrinogen degradation products in the urine of patients with nephrotic syndrome].
    Ena IaM
    Sov Med; 1975 Jul; (7):85-9. PubMed ID: 1216058
    [No Abstract]   [Full Text] [Related]  

  • 27. Isoelectric points of two molecular forms of human urinary urokinase determined by density-gradient isoelectric focusing and isotachoelectrophoresis.
    Miwa N; Sawada T; Suzuki A
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1513-6. PubMed ID: 7049421
    [No Abstract]   [Full Text] [Related]  

  • 28. Alteration of polypeptide backbone structure as determined by circular dichroic spectral analysis in relation to change of plasminogen activator activity of two forms of human urinary urokinase denatured with guanidine hydrochloride.
    Miwa N; Yamashita A; Suzuki A
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3669-78. PubMed ID: 6761000
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on unexplained renal hematuria. II. Experimental studies on changes in fibrinolytic enzyme systems of dogs due to renal venous congestion and ischemia (author's transl)].
    Hayashi M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):60-73. PubMed ID: 7024605
    [No Abstract]   [Full Text] [Related]  

  • 31. Spectrometric determination of urokinase in urine after gel filtration, using the chromogenic substrate S-2444.
    Paar D; Maruhn D
    J Clin Chem Clin Biochem; 1980 Sep; 18(9):557-62. PubMed ID: 7003055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder.
    Diamandis M; Veljkovic DK; Derome F; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):463-4. PubMed ID: 18600101
    [No Abstract]   [Full Text] [Related]  

  • 33. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
    Bouissou F; Barthe P; Boneu B
    Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative studies on two active enzyme forms of human urinary urokinase. I. Purification by serial column chromatography and homogeneity analyses of molecular weight and isoelectric point.
    Miwa N; Takayanagi H; Suzuki A
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):463-71. PubMed ID: 7023709
    [No Abstract]   [Full Text] [Related]  

  • 36. The pH dependence of the binding of pro-urokinase to fibrin/celite.
    Pannell R; Angles-Cano E; Gurewich V
    Thromb Haemost; 1990 Dec; 64(4):556-8. PubMed ID: 2128139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of urinary fibrin-fibrinogen degradation products (FDP) in various infantile glomerular nephorapathies].
    Tamborine G; Barbieri U; Forese S; Cocconcelli P; Zervos N
    Minerva Pediatr; 1977 Mar; 29(8):525-8. PubMed ID: 865431
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
    Zühlke V; Hölscher M; Reichel W; Pernice G
    Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosyl residues of two molecular forms of human urinary urokinase: their ionization mode characterized by spectrophotometric and CD titrations and reactivity with cyanuric fluoride in relation to enzymic activity.
    Miwa N; Sawada T; Suzuki A
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1136-43. PubMed ID: 6758771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.